Ching Sung Hsu
Voorzitter bij Formosa Lithium Iron Oxide Corp.
Profiel
Ching Sung Hsu is currently the Chairman at Formosa Lithium Iron Oxide Corp.
Prior to this, he held the position of Vice Chairman at United BioPharma, Inc. and UBI Pharma Inc. He also served as a Director at Changs Ascending Enterprise Co., Ltd.
and Taiwan Leader Biotech Corp.
where he held the position of Director from 2009 to 2017.
Mr. Hsu completed his undergraduate degree from Feng Chia University.
Actieve functies van Ching Sung Hsu
| Bedrijven | Functie | Begin |
|---|---|---|
| Formosa Lithium Iron Oxide Corp. | Voorzitter | - |
Eerdere bekende functies van Ching Sung Hsu
| Bedrijven | Functie | Einde |
|---|---|---|
| TAIWAN LEADER BIOTECH CORP. | Directeur/Bestuurslid | 30-03-2017 |
| UBI PHARMA INC. | Directeur/Bestuurslid | - |
| UNITED BIOPHARMA INC | Directeur/Bestuurslid | - |
| CHANGS ASCENDING ENTERPRISE CO., LTD. | Directeur/Bestuurslid | - |
Opleiding van Ching Sung Hsu
| Feng Chia University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CHANGS ASCENDING ENTERPRISE CO., LTD. | Producer Manufacturing |
| TAIWAN LEADER BIOTECH CORP. | Health Technology |
| UBI PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
| Formosa Lithium Iron Oxide Corp. |
